Valuation: Bayer AG

Market Cap 46.14B 52.47B 42.87B 39.43B 73.94B 5,081B 75.26B 513B 200B 2,478B 197B 193B 8,598B P/E 2026 *
20.3x
P/E 2027 * 15.2x
Enterprise Value 77.99B 88.67B 72.45B 66.63B 125B 8,587B 127B 866B 338B 4,188B 333B 326B 14,531B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
100%
Yield 2026 *
0.49%
Yield 2027 * 1.34%
1 day-1.81%
1 week-3.19%
Current month-4.57%
1 month+19.69%
3 months+15.38%
6 months+3.69%
Current year+24.83%
1 week 45.82
Extreme 45.82
48.49
1 month 38.67
Extreme 38.67
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,530 0.0002%
18/03/26 Buy

Chairman

2,671 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-3.19%+62.25%-10.27% 52.66B
+1.51%+1.10%+47.96%+157.34% 1,037B
+1.01%+3.76%+53.38%+51.60% 615B
+1.03%+0.76%+34.52%+79.02% 448B
+5.14%+5.40%+33.75%+27.79% 326B
+1.85%+3.57%+37.09%+40.59% 293B
-0.11%+0.48%+18.87%+17.70% 264B
+0.25%-4.62%-27.66%-41.76% 216B
+1.72%-0.84%+19.16%+56.52% 198B
+0.26%-4.36%+14.79%+67.86% 162B
Average +0.98%+0.85%+29.41%+44.64% 361.01B
Weighted average by Cap. +1.41%+1.43%+35.55%+74.37%

Financials

2026 *2027 *
Net sales 45.6B 51.85B 42.37B 38.96B 73.07B 5,021B 74.38B 507B 198B 2,449B 195B 190B 8,497B 46.76B 53.16B 43.44B 39.95B 74.92B 5,148B 76.26B 519B 203B 2,511B 200B 195B 8,712B
Net income 2.13B 2.42B 1.98B 1.82B 3.41B 234B 3.47B 23.62B 9.21B 114B 9.08B 8.88B 396B 2.93B 3.33B 2.72B 2.51B 4.7B 323B 4.78B 32.58B 12.71B 157B 12.52B 12.25B 546B
Net Debt 31.84B 36.2B 29.58B 27.21B 51.02B 3,506B 51.94B 354B 138B 1,710B 136B 133B 5,933B 28.71B 32.65B 26.67B 24.53B 46.01B 3,162B 46.83B 319B 124B 1,542B 123B 120B 5,350B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
23/07/26 46.20 -1.64% 2,347,666
22/07/26 €46.97 -1.36% 1,856,037
21/07/26 €47.62 +0.66% 1,471,496
20/07/26 €47.31 -2.37% 1,487,548
17/07/26 €48.46 +1.55% 2,726,516
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.97EUR
Average target price
54.92EUR
Spread / Average Target
+16.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock